期刊文献+

IL-10在Plasmodium yoelii 17XL和Plasmodium chabaudi AS疟原虫混合感染宿主病理损伤中的作用研究 被引量:1

The Role of IL-10 on the Host Pathological Injury in DBA/2 Mice Mixed Infection with Plasmodium yoelii 17XL and Plasmodium chabaudi AS
下载PDF
导出
摘要 为探讨IL-10在致死型约氏疟原虫(Plasmodium yoelii 17XL,P.y17XL)和夏氏疟原虫(Plasmodiumchabaudi AS,P.cAS)混合感染宿主病理损伤中的作用,用P.y17XL、P.cAS和P.y17XL+P.cAS分别感染DBA/2小鼠,计数红细胞感染率;感染后第3、5、8、10、12和19天分别尾静脉取血,肝素抗凝后短暂离心,采用高纯度DNA提取试剂盒抽提DNA,实时定量PCR检测虫负荷水平;感染后第0、1、3、5、8、10、12和15天制备脾细胞悬液,ELISA检测脾细胞培养上清中IL-10水平。实验结果发现,P.y17XL单独感染和混合感染小鼠IL-10水平在感染后第5天和第8天分别达峰值,随后开始下降至正常水平,小鼠虫血症均达中等水平,存活率100%;相比P.cAS感染小鼠IL-10在感染后第3天突然出现高水平升高并且维持时间较长;于感染后第8天达峰值,是同天P.y17XL单独感染和混合感染小鼠IL-10水平的2倍,虫血症水平较高,小鼠全部死亡。同时实时定量PCR结果发现,混合感染小鼠,于感染后3~12 d P.y17XL增殖占优势,而感染后15~19 d则P.cAS增殖处于优势状态。表明以IL-10为核心的免疫调节网络与疟疾感染过程中病理损伤密切相关。同时提示混合感染小鼠应答模式与P.y17XL感染小鼠的应答模式相同。 In order to investigate the role of IL-10 on the host pathological injury mixed infection with lethal Plasmodium yoelii 17XL (P.yl7XL) and Plasmodium chabaudi AS (P.cAS) , DBA/2 mice were infected with P.yI7XL, P.cAS, or P.yI7XL + P. cAS respectively, and counted the infection rate of erythroeytes for each group of mice. Parasitemia and mortality were monitored daily. Tail blood collected at different time points was anti-coagulated by heparin on day 3, 5, 8, I0, 12 and 19 post infection (PI) and centrifuged briefly for DNA extraction using a high pure blood genome DNA extraction kit, real-time quantitative (RTQ) PCR for determining the level of parasite burden. On day 0, 1, 3, 5, 8, 10, 12 and 15 PI splenocyte IL-10 were dynamically detected by ELISA. The results showed that the level of IL-10 in DBA/2 mice infected by P. yl7XL alone and the mixed infection got its peak on day 5 and 8 PI, and then began to decline to normal level, parasitemia reached a middle level, the survival rate was 100% ; comparatively the IL-10 level in DBA/2 mice infected by P. cAS increased suddenly on day 3 PI and then maintained a fairly long time, and reached a peak on day 8 PI and contained 2 times higher than that of the other infected mice on the same day, and then all mice died. At the same time it was found the RTQ-PCR results that in DBA/2 mice, P.ylTXL proliferalion predominated from day 3~12 PI, however, on days 15~19 PIP. cAS proliferation laid predominance. Indicated that IL-10 as the core of the immune regulatory network closely correlated with the pathological injury in malaria infection process. At the same time, it was pointed out that the immune response mode in P.ylTXL infection mice was the same as the one in the mixed infection mice.
出处 《微生物学杂志》 CAS CSCD 2013年第1期39-43,共5页 Journal of Microbiology
基金 黑龙江省教育厅青年学术骨干支持计划项目(1155G55)
关键词 IL-10 P y17XL和P cAS混合感染 病理损伤 IL-10 mixed infection with Plasmodium yoelii 17XL and Plasmodium chabaudi AS pathological injury
  • 相关文献

参考文献16

  • 1World Health Organization[ R]. World Malaria Report,2012.
  • 2Murray CJ, Rosenfeld LC, Lim SS, et al. Global malaria mor- tality between 1980 and 2010: a systematic analysis[J]. Lan- cet,2012,379(9814) :413-431.
  • 3lmwong, M. , S. Pukrittayakamee, A. C. Grtiner, et al. Prac- tical PCR genotyping protocols for Plasmodium vivax using Pvcs and Pvmspl[J]. Malar. J,2005,4( 1 ) :20.
  • 4Mayxay M, Pukrittayakamee S, Newton PN, et al. Mixe-spe- cies malaria infections in humans[ J ]. Trends Parssitol, 2004,20 (5) :233-40.
  • 5Zimmerman PA, Melotra RK, Kasehagen LJ, et al. Why we need to know more about mixed Plasmodium species infections in humans [ J ] ? Trends Parasitol, 2004,20 ( 9 ) :440--447.
  • 6Njau JD, Goodman CA, Kachur SP, et al. The costs of intro- ducing artemisinin-based combination therapy: evidence from district- wide implementation in rural Tanzania [ J ]. Malar J, 2008,7 ( 1 ) :4.
  • 7Pierce Susan K, Louis H. Miller. World Malaria Day 2009: What Malaria Knows about the Immune System That Immunolo- gists Still Do Not [ J ]. The Journal of Immunology, 2009, 182: 5171-5177.
  • 8Joss, A. , M. Akdis, A. Faith, et al. IL-IO directly acts on T cells by specifically altering the CD28 co-stimulation pathway [J].Eur. J. Immunol,2000,30(6):1683-1690.
  • 9Artavanis-Tsakonas K, Tongren JE, Riley EM. The war be- tween the ma]aria parasite and the immune system: immunity, immunoregulation and immunopathology[ J]. Ciin Exp Immu- nol, 2003,133 ( 2 ) : 145-152.
  • 10Couper Krq, Blount DG, Riley EM. IL-10: the master regulator of immunity to infection [ J ]. J Immunol, 2008,180 (9) : 5771 - 5777. Review.

二级参考文献34

  • 1Fiorentino DF, Bond MW, Mosmann TR. Two types of mouse T helpercell. IV. Th2 clones secrete a factor that inhibits cytokine productionby Thl clones[J]. J Exp Med, 1989, 170(6) : 2081 -2095.
  • 2Sabat R, Griitz G,Warszawska K, et al. Biology of interleukin-10[J].Cytokine Growth Factor Rev, 2010, 21 (5) : 331 -344.
  • 3L6pez P, Gutierrez C, Sudrez A. IL-10 and TNFalpha genotypes inSLE[ J]. J Biomed Biotechnol, 2010,2010 : 838390.
  • 4Yuzhalin A. The role of interleukin DNA polymorphisms in gastriccancer[ J].Hum Immunol, 2011 , 72(11) : 1128 - 1136.
  • 5Redford PS, Murray PJ, O 'Garra A. The role of IL-10 in immuneregulation during M. tuberculosis infection [ J ]. Mucosal Immunol,2011,4(3) : 261 -270.
  • 6Saraiva M, OGarra A. The regulation of IL-10 production by immunecells[J]. Nat Rev Immunol, 2010, 10(3) : 170-181.
  • 7Wilke CM, Wei S,Wang L, et al. Dual biological effects of thecytokines interleukin-10 and interferon-gamma [ J ]. Cancer ImmunolImmunother, 2011,60(11) : 1529 -1541.
  • 8Moore KW, de Waal Malefyt R, Coffman RL, et al. Interleukin-10and the interleukin-10 receptor[ J ]. Annu Rev Immunol, 2001, 19:683 -765.
  • 9Curiel TJ, Wei S, Dong H, Alvarez X, et al. Blockade of B7-H1improves myeloid dendritic cell-mediated antitumor immunity [ J ]. NatMed, 2003, 9(5) : 562 -567.
  • 10Wang B, Jiao Z, Shao X, et al. Phenotypic alterations of dendriticcells are involved in suppressive activity of trichosanthin-inducedCD8 + CD28— regulatory Tcells[J]. J Immunol, 2010, 185(1) : 79-88.

共引文献63

同被引文献12

  • 1Penet MF, Kober F, Confort-Gouny S, et al. Magnetic resonance spectroscopy reveals an impaired brain metabolic profile in mice re- sistant to cerebral malaria infected with Plasmodium berghei ANKA [ J]. J Biol Chem, 2007,282(19) : 14505-1451.
  • 2Amante, F. H. , Stanley, A. C. , Randall, L. M. , et al. A role for natural regulatory T ceils in the pathogenesis of experimental cerebral malaria [ J]. Am J Pathol, 2007,171 (2) :548-559.
  • 3Nie CQ, Bernard NJ, Schofield L, et al. CD4 +CD25 + regulato- ry T cells suppress CD4 + T-cell function and inhibit the develop- ment of Plasmodium berghei-specific TH1 responses involved in cerebral malaria pathogenesis [ J ]. Infect Immunol, 2007,75 (5) : 2275 -2288.
  • 4Hunt NH, Grau GE. Cytokines: accelerators and brakes in the pathogenesis of cerebral malaria [ J ]. Trends Immunol, 2003,24 (9) :491-499.
  • 5Sun CM, Deriaud E, Leclerc C, et al. Upon TLR9 signaling, CD5 + B cells control the IL-12-dependent Thl-priming capacity of neonatal DCs[J]. Immunity, 2005,22(4) :467-477.
  • 6Dascombe M J, Nahrevanian H. Pharmacological assessment of the role of nitric oxide in mice infected with lethal and nonlethal spe- cies of malaria[J]. Parasite Immunol, 2003,25(3) :149-159.
  • 7Yanez DM, Manning DD, Cooley AJ, et al. Participation of lym- phocyte subpopulations in the pathogenesis of experimental murine cerebral malaria [ J ]. J Immunol, 1996,157 (4) : 1620 -1624.
  • 8Artavanis-Tsakonas K, Tongren JE, Riley EM. The war between the malaria parasite and the immune system: immunity, immuno- regulation and immunopathology [ J]. Clin Exp Immunol, 2003, 133(2) :145-152.
  • 9Engwerda C, Belnoue E, Gruner AC, et al. Experimental mod- els of cerebral malaria[ J]. Curr Top Mimbiol Immunol, 2005, 297 : 103-143.
  • 10Hansen DS, Schofield L. Natural regulatory T cells in malaria: host or parasite allies [ J ]. PLoS Pathog, 2010,6 (4) : el 000771.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部